H Lassmann Selected Research

H Lassmann Research Topics

Disease

24	Multiple Sclerosis 01/2021 - 06/2000
10	Inflammation (Inflammations) 01/2014 - 07/2000
10	Demyelinating Diseases (Demyelinating Disease) 11/2007 - 06/2000
9	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2002 - 09/2000
5	Disease Progression 01/2007 - 06/2000
2	Leukoencephalopathies 03/2006 - 07/2000
2	Hypoxia (Hypoxemia) 01/2005 - 12/2004
2	Necrosis 07/2001 - 10/2000
2	Autoimmune Diseases (Autoimmune Disease) 01/2001 - 09/2000
1	Neoplasms (Cancer) 01/2019
1	Autoimmune Diseases of the Nervous System 01/2019
1	Edema (Dropsy) 07/2008
1	Infections 11/2007
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2005
1	Glioblastoma (Glioblastoma Multiforme) 12/2004
1	Persistent Infection 01/2002
1	Vasculitis (Vasculitides) 11/2001
1	Crohn Disease (Crohn's Disease) 11/2001
1	Bacterial Meningitis 10/2001
1	Gliosis 08/2001
1	Central Nervous System Diseases (CNS Diseases) 10/2000
1	Encephalomyelitis (Myeloencephalitis) 07/2000

Drug/Important Bio-Agent (IBA)

8	Myelin-Oligodendrocyte GlycoproteinIBA 01/2007 - 07/2000
5	CytokinesIBA 01/2014 - 08/2001
4	AntibodiesIBA 01/2019 - 10/2001
4	Proteins (Proteins, Gene)FDA Link 12/2004 - 07/2000
3	Neuroprotective AgentsIBA 03/2006 - 07/2000
3	Peptides (Polypeptides)IBA 08/2001 - 11/2000
2	LigandsIBA 01/2014 - 10/2000
2	EnzymesIBA 01/2007 - 10/2001
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 03/2006 - 07/2000
2	Complement System Proteins (Complement)IBA 12/2005 - 01/2002
2	Chemokine ReceptorsIBA 12/2003 - 01/2002
2	Myelin ProteinsIBA 01/2002 - 06/2000
2	Caspase 3 (Caspase-3)IBA 10/2001 - 07/2001
1	IronIBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2014
1	Interferon-betaIBA 07/2008
1	Glatiramer Acetate (Copaxone)FDA Link 07/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2008
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2008
1	Therapeutic UsesIBA 07/2008
1	Interferon-alpha (Interferon Alfa)IBA 11/2007
1	Nerve Growth Factors (Neurotrophins)IBA 03/2006
1	Oxygen (Dioxygen)IBA 01/2005
1	NitrogenIBA 01/2005
1	AntigensIBA 12/2004
1	Fc Receptors (Fc Receptor)IBA 01/2002
1	RNA (Ribonucleic Acid)IBA 01/2002
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2002
1	AnaphylatoxinsIBA 01/2002
1	ChemokinesIBA 11/2001
1	Peptide Hydrolases (Proteases)FDA Link 11/2001
1	CorticosteroneIBA 08/2001
1	Formaldehyde (Formol)FDA Link 07/2001
1	Histocompatibility Antigens Class IIIBA 06/2001
1	Calcium Channels (Calcium Channel)IBA 06/2001
1	CalciumIBA 06/2001
1	Nerve Growth Factor (NGF)IBA 01/2001
1	Myelin Basic ProteinIBA 01/2001
1	Lymphotoxin-alpha (Lymphotoxin)IBA 10/2000
1	Type I Tumor Necrosis Factor ReceptorsIBA 10/2000
1	Type II Tumor Necrosis Factor ReceptorsIBA 10/2000
1	Milk Proteins (Milk Protein)IBA 09/2000
1	ButyrophilinsIBA 09/2000
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2000
1	Amyloid beta-PeptidesIBA 07/2000

Therapy/Procedure

9	Therapeutics 11/2007 - 06/2000
2	Immunotherapy 01/2019 - 11/2004
1	Plasmapheresis 01/2007
1	Investigational Therapies (Experimental Therapy) 10/2000